{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:22:59Z","timestamp":1779222179152,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1A2C3003334"],"award-info":[{"award-number":["NRF-2021R1A2C3003334"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1A5A2024418"],"award-info":[{"award-number":["NRF-2018R1A5A2024418"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017M3C7A1025602"],"award-info":[{"award-number":["2017M3C7A1025602"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.brainres.2021.147445","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T09:34:54Z","timestamp":1616492094000},"page":"147445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Naloxone-induced analgesia mediated by central kappa opioid system in chronic inflammatory pain"],"prefix":"10.1016","volume":"1762","author":[{"given":"Grace J.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin Ae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yea Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seog Bae","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2021.147445_b0005","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.bjp.0707277","article-title":"Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists","volume":"151","author":"Abul-Husn","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2021.147445_b0010","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.brainres.2021.147445_b0015","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41386-018-0294-3","article-title":"Dynorphin-kappa opioid receptor activity in the central amygdala modulates binge-like alcohol drinking in mice","volume":"44","author":"Anderson","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2021.147445_b0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuroscience.2018.10.015","article-title":"Mu-opioid receptor (MOR) biased agonists induce biphasic dose-dependent hyperalgesia and analgesia, and hyperalgesic priming in the rat","volume":"394","author":"Araldi","year":"2018","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.brainres.2021.147445_b0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuron.2010.03.002","article-title":"Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain","volume":"66","author":"Baliki","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2021.147445_b0030","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ejpain.2007.12.007","article-title":"Signal valence in the nucleus accumbens to pain onset and offset","volume":"12","author":"Becerra","year":"2008","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.brainres.2021.147445_b0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0091-3057(93)90331-M","article-title":"Naloxone-induced analgesia: involvement of kappa-opiate receptors","volume":"46","author":"Bianchi","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.brainres.2021.147445_b0040","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0006-8993(91)90772-N","article-title":"Synergistic analgesic interactions between the periaqueductal gray and the locus coeruleus","volume":"558","author":"Bodnar","year":"1991","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.brainres.2021.147445_b0045","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrn3516","article-title":"Cognitive and emotional control of pain and its disruption in chronic pain","volume":"14","author":"Bushnell","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2021.147445_b0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fphar.2014.00253","article-title":"Does the kappa opioid receptor system contribute to pain aversion?","volume":"5","author":"Cahill","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.brainres.2021.147445_b0055","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3389\/fnins.2015.00466","article-title":"Sex differences in kappa opioid receptor function and their potential impact on addiction","volume":"9","author":"Chartoff","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.brainres.2021.147445_b0060","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/npp.2010.137","article-title":"The therapeutic potential of kappa-opioids for treatment of pain and addiction","volume":"36","author":"Chavkin","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2021.147445_b0065","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/ALN.0000000000000170","article-title":"Buprenorphine-naloxone therapy in pain management","volume":"120","author":"Chen","year":"2014","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.brainres.2021.147445_b0070","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0091-3057(03)00144-8","article-title":"Possible antinociceptive mechanisms of opioid receptor antagonists in the mouse formalin test","volume":"75","author":"Choi","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2021.147445_b0075","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neuropharm.2018.12.002","article-title":"Females are less sensitive than males to the motivational- and dopamine-suppressing effects of kappa opioid receptor activation","volume":"146","author":"Conway","year":"2019","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.brainres.2021.147445_b0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ymeth.2004.08.021","article-title":"Integrating gene and protein expression data: pattern analysis and profile mining","volume":"35","author":"Cox","year":"2005","journal-title":"Methods"},{"key":"10.1016\/j.brainres.2021.147445_b0085","unstructured":"Dongnan Yu, Y.Z., Can Cui, Ruichun Long, Jue Ma, 2020. Mechanism and antagonism of naloxone hydrochloride on neuropathic pain in rats. Int. J. Clin. Exp. Med. 13(1), 134\u2013140."},{"issue":"6","key":"10.1016\/j.brainres.2021.147445_b0095","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00002508-200211000-00001","article-title":"An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms","volume":"18","author":"Dworkin","year":"2002","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.brainres.2021.147445_b0100","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pain.2010.06.019","article-title":"The evidence for pharmacological treatment of neuropathic pain","volume":"150","author":"Finnerup","year":"2010","journal-title":"Pain"},{"issue":"26","key":"10.1016\/j.brainres.2021.147445_b0105","doi-asserted-by":"crossref","first-page":"9580","DOI":"10.1523\/JNEUROSCI.0731-14.2015","article-title":"Pronociceptive and antinociceptive effects of buprenorphine in the spinal cord dorsal horn cover a dose range of four orders of magnitude","volume":"35","author":"Gerhold","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2021.147445_b0110","first-page":"219","article-title":"The pharmacological basis of opioids","volume":"12","author":"Ghelardini","year":"2015","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"10.1016\/j.brainres.2021.147445_b0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF02431530","article-title":"\u201cParadoxical\u201d analgesia induced by naloxone and naltrexone","volume":"96","author":"Greeley","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2021.147445_b0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neuropharm.2016.12.008","article-title":"Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists","volume":"116","author":"Grenald","year":"2017","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.brainres.2021.147445_b0125","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/bfgp\/3.3.212","article-title":"Integrated transcriptome and proteome data: the challenges ahead","volume":"3","author":"Hack","year":"2004","journal-title":"Brief Funct. Genomic Proteomic"},{"key":"10.1016\/j.brainres.2021.147445_b0130","doi-asserted-by":"crossref","unstructured":"Hutchinson, M.R., Zhang, Y., Brown, K., Coats, B.D., Shridhar, M., Sholar, P.W., Patel, S.J., Crysdale, N.Y., et al., 2008. Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur. J. Neurosci. 28, 20\u201329.","DOI":"10.1111\/j.1460-9568.2008.06321.x"},{"issue":"4","key":"10.1016\/j.brainres.2021.147445_b0135","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nn1207","article-title":"Glutamatergic activation of anterior cingulate cortex produces an aversive teaching signal","volume":"7","author":"Johansen","year":"2004","journal-title":"Nat. Neurosci."},{"issue":"14","key":"10.1016\/j.brainres.2021.147445_b0140","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.1073\/pnas.141218998","article-title":"The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex","volume":"98","author":"Johansen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2021.147445_b0145","doi-asserted-by":"crossref","unstructured":"Juarez-Salinas, D.L., Braz, J.M., Etlin, A., Gee, S., Sohal, V., Basbaum, A.I., 2019. GABAergic cell transplants in the anterior cingulate cortex reduce neuropathic pain aversiveness. Brain 142, 2655\u20132669.","DOI":"10.1093\/brain\/awz203"},{"key":"10.1016\/j.brainres.2021.147445_b0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neulet.2016.06.060","article-title":"Pain relief induces dopamine release in the rat nucleus accumbens during the early but not late phase of neuropathic pain","volume":"629","author":"Kato","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2021.147445_b0155","first-page":"166","article-title":"Thioperamide-induced antinociception is mediated through endogenous opioid system in the dentate gyrus of adult rats","volume":"1","author":"Khalilzadeh","year":"2010","journal-title":"Arch. SID"},{"key":"10.1016\/j.brainres.2021.147445_b0160","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/jpet.107.127415","article-title":"Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats","volume":"323","author":"Knoll","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2021.147445_b0165","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0014-2999(96)00520-1","article-title":"Peripheral kappa 1-opioid receptor-mediated analgesia in mice","volume":"310","author":"Kolesnikov","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2021.147445_b0170","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jpain.2008.03.005","article-title":"Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling","volume":"9","author":"Largent-Milnes","year":"2008","journal-title":"J. Pain"},{"key":"10.1016\/j.brainres.2021.147445_b0175","doi-asserted-by":"crossref","first-page":"16873","DOI":"10.1038\/s41598-019-53149-7","article-title":"The analgesic effect of refeeding on acute and chronic inflammatory pain","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2021.147445_b0180","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.neuropharm.2018.04.009","article-title":"Peripheral GABAA receptor-mediated signaling facilitates persistent inflammatory hypersensitivity","volume":"135","author":"Lee","year":"2018","journal-title":"Neuropharmacology"},{"issue":"21","key":"10.1016\/j.brainres.2021.147445_b0185","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1523\/JNEUROSCI.0274-19.2019","article-title":"Kappa opioid receptors drive a tonic aversive component of chronic pain","volume":"39","author":"Liu","year":"2019","journal-title":"J. Neurosci."},{"issue":"564\u2013573","key":"10.1016\/j.brainres.2021.147445_b0190","article-title":"Pain-induced negative affect is mediated via recruitment of the nucleus accumbens kappa opioid system","volume":"102","author":"Massaly","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2021.147445_b0195","doi-asserted-by":"crossref","unstructured":"Mattioli, T.A., Milne, B., Cahill, C.M., 2010. Ultra-low dose naltrexone attenuates chronic morphine-induced gliosis in rats. Mol. Pain 6, 22.","DOI":"10.1186\/1744-8069-6-22"},{"issue":"3","key":"10.1016\/j.brainres.2021.147445_b0200","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1152\/jn.00320.2004","article-title":"Kappa opioids inhibit physiologically identified medullary pain modulating neurons and reduce morphine antinociception","volume":"93","author":"Meng","year":"2005","journal-title":"J. Neurophysiol."},{"issue":"1","key":"10.1016\/j.brainres.2021.147445_b0205","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00431775","article-title":"Naloxone injections into the periaqueductal grey area and arcuate nucleus block analgesia in defeated mice","volume":"87","author":"Miczek","year":"1985","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1016\/j.brainres.2021.147445_b0210","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jpain.2012.07.006","article-title":"The etiology and symptomatology of spontaneous pain","volume":"13","author":"Mogil","year":"2012","journal-title":"J. Pain"},{"key":"10.1016\/j.brainres.2021.147445_b0215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/sj.npp.1300527","article-title":"Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state","volume":"30","author":"Narita","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.brainres.2021.147445_b0220","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/j.pain.0000000000001458","article-title":"Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain","volume":"160","author":"Navratilova","year":"2019","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.brainres.2021.147445_b0225","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.brainresrev.2008.12.014","article-title":"Forebrain pain mechanisms","volume":"60","author":"Neugebauer","year":"2009","journal-title":"Brain Res. Rev."},{"issue":"3","key":"10.1016\/j.brainres.2021.147445_b0230","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1073858403261077","article-title":"The amygdala and persistent pain","volume":"10","author":"Neugebauer","year":"2004","journal-title":"Neuroscientist"},{"key":"10.1016\/j.brainres.2021.147445_b0235","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.tips.2010.04.003","article-title":"Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopaminergic transmission","volume":"31","author":"Niikura","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.brainres.2021.147445_b0240","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12467","article-title":"Dynorphinergic system alterations in the corticostriatal circuitry of neuropathic mice support its role in the negative affective component of pain","volume":"18","author":"Palmisano","year":"2019","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.brainres.2021.147445_b0245","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1126\/science.277.5328.968","article-title":"Pain affect encoded in human anterior cingulate but not somatosensory cortex","volume":"277","author":"Rainville","year":"1997","journal-title":"Science"},{"issue":"1-2","key":"10.1016\/j.brainres.2021.147445_b0250","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.lfs.2010.10.007","article-title":"Sex differences in kappa opioid pharmacology","volume":"88","author":"Rasakham","year":"2011","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.brainres.2021.147445_b0255","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ilar.40.3.111","article-title":"Inflammatory models of pain and hyperalgesia","volume":"40","author":"Ren","year":"1999","journal-title":"ILAR J."},{"issue":"6","key":"10.1016\/j.brainres.2021.147445_b0260","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nrd1107","article-title":"Neurotrophic factors as novel therapeutics for neuropathic pain","volume":"2","author":"Sah","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.brainres.2021.147445_b0265","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00000542-199609000-00007","article-title":"Capsaicin-evoked mechanical allodynia and hyperalgesia cross nerve territories. Evidence for a central mechanism","volume":"85","author":"Sang","year":"1996","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.brainres.2021.147445_b0270","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1185\/03007991003787318","article-title":"Innovative pain therapy with a fixed combination of prolonged-release oxycodone\/naloxone: a large observational study under conditions of daily practice","volume":"26","author":"Schutter","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.brainres.2021.147445_b0275","doi-asserted-by":"crossref","first-page":"249","DOI":"10.36076\/ppj.2011\/14\/249","article-title":"Peripherally acting opioids and clinical implications for pain control","volume":"14","author":"Sehgal","year":"2011","journal-title":"Pain Physician"},{"key":"10.1016\/j.brainres.2021.147445_b0280","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-3-211-78205-7_4","article-title":"Electrically and mechanically evoked nociceptive neuronal responses in the rat anterior cingulate cortex","volume":"101","author":"Shyu","year":"2008","journal-title":"Acta Neurochir. Suppl."},{"key":"10.1016\/j.brainres.2021.147445_b0285","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/emboj\/17.4.886","article-title":"Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal","volume":"17","author":"Simonin","year":"1998","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.brainres.2021.147445_b0290","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00213-010-1838-3","article-title":"Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone","volume":"210","author":"Tompkins","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2021.147445_b0295","doi-asserted-by":"crossref","unstructured":"Wang, X., Ma, S., Wu, H., Shen, X., Xu, S., Guo, X., Bolick, M.L., Wu, S., et al., 2018, Macrophage migration inhibitory factor mediates peripheral nerve injury-induced hypersensitivity by curbing dopaminergic descending inhibition. Exp. Mol. Med. 50, e445.","DOI":"10.1038\/emm.2017.271"},{"issue":"13","key":"10.1016\/j.brainres.2021.147445_b0300","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.3390\/ijms20133130","article-title":"Chronic pain: structural and functional changes in brain structures and associated negative affective states","volume":"20","author":"Yang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2021.147445_b0305","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1126\/science.1060952","article-title":"Regional mu opioid receptor regulation of sensory and affective dimensions of pain","volume":"293","author":"Zubieta","year":"2001","journal-title":"Science"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899321003024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899321003024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:23:56Z","timestamp":1777389836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899321003024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":60,"alternative-id":["S0006899321003024"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2021.147445","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naloxone-induced analgesia mediated by central kappa opioid system in chronic inflammatory pain","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2021.147445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"147445"}}